BRIVARACETAM INJECTION

BRIVARACETAM INJECTION was reported 4762 times

BRIVARACETAM INJECTION is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 JC POLYOMAVIRUS TEST 8 0.5333
1 BROMODERMA 4 0.4000
2 EPILEPSY SURGERY 8 0.3200
3 NEW ONSET REFRACTORY STATUS EPILEPTICUS 33 0.3000
4 AUTOIMMUNE APLASTIC ANAEMIA 4 0.2857
5 MATERNAL DEATH 8 0.2581
6 EPILEPSIA PARTIALIS CONTINUA 8 0.1905
7 SEVERE MYOCLONIC EPILEPSY OF INFANCY 5 0.1613
8 AUTOMATISM EPILEPTIC 5 0.1389
9 INTESTINAL ATRESIA 13 0.1204
10 BRONCHIAL ASPIRATION PROCEDURE 2 0.1111
11 DISRUPTIVE MOOD DYSREGULATION DISORDER 8 0.1081
12 POST STROKE DEPRESSION 4 0.1053
13 CEREBRAL LOBOTOMY 2 0.0952
14 JUVENILE MYOCLONIC EPILEPSY 5 0.0794
15 SCALLOPED TONGUE 2 0.0667
16 POSTICTAL PARALYSIS 15 0.0620
17 PARTIAL SEIZURES WITH SECONDARY GENERALISATION 29 0.0620
18 UMBILICAL HAEMORRHAGE 9 0.0596
19 MULTIPLE-DRUG RESISTANCE 175 0.0564
20 ABNORMAL PRODUCT OF CONCEPTION 1 0.0556
21 VAGAL NERVE STIMULATOR IMPLANTATION 17 0.0556
22 PULMONARY HAEMORRHAGE NEONATAL 4 0.0435
23 SUDDEN UNEXPLAINED DEATH IN EPILEPSY 20 0.0374
24 AFRICAN TRYPANOSOMIASIS 1 0.0370
25 NEUROPROSTHESIS IMPLANTATION 5 0.0360
26 FOCAL DYSCOGNITIVE SEIZURES 40 0.0351
27 SEIZURE CLUSTER 27 0.0326
28 CATASTROPHIC REACTION 2 0.0317
29 SIDEROBLASTIC ANAEMIA 4 0.0286
30 LESION EXCISION 4 0.0282
31 INTERMITTENT EXPLOSIVE DISORDER 3 0.0256
32 CENTRAL SLEEP APNOEA SYNDROME 8 0.0246
33 IDIOPATHIC GENERALISED EPILEPSY 2 0.0235
34 DRUG CLEARANCE INCREASED 5 0.0224
35 ECG SIGNS OF MYOCARDIAL ISCHAEMIA 5 0.0219
36 ABDOMINAL WALL OPERATION 1 0.0217
37 CHANGE IN SEIZURE PRESENTATION 14 0.0216
38 PARTIAL SEIZURES 110 0.0210
39 ATONIC SEIZURES 18 0.0210
40 VESTIBULAR MIGRAINE 5 0.0207
41 POSTICTAL PSYCHOSIS 3 0.0192
42 BRAIN OPERATION 43 0.0188
43 GINGIVITIS ULCERATIVE 4 0.0186
44 MYOCLONIC EPILEPSY 28 0.0184
45 HALLUCINATION, OLFACTORY 8 0.0184
46 TONIC CONVULSION 26 0.0183
47 PETIT MAL EPILEPSY 90 0.0176
48 VENTRICULO-PERITONEAL SHUNT 2 0.0175
49 SEIZURE 1984 0.0172
50 PRODUCT SUBSTITUTION ERROR 2 0.0171
51 ACQUIRED CARDIAC SEPTAL DEFECT 1 0.0169
52 SIMPLE PARTIAL SEIZURES 13 0.0161
53 PSYCHOGENIC SEIZURE 15 0.0160
54 UNEMPLOYMENT 3 0.0155
55 MEDICAL DEVICE BATTERY REPLACEMENT 2 0.0148
56 DEJA VU 4 0.0145
57 LACTATION INSUFFICIENCY 3 0.0145
58 AMNESTIC DISORDER 7 0.0144
59 MIXED ANXIETY AND DEPRESSIVE DISORDER 5 0.0135
60 ANTICONVULSANT DRUG LEVEL INCREASED 21 0.0130
61 GAZE PALSY 22 0.0129
62 PROPOFOL INFUSION SYNDROME 9 0.0128
63 STATUS EPILEPTICUS 144 0.0127
64 HYPERAMMONAEMIC ENCEPHALOPATHY 22 0.0126
65 BONE HYPERTROPHY 2 0.0124
66 AORTIC VALVE THICKENING 2 0.0124
67 BEHAVIOUR DISORDER 67 0.0124
68 INFANTILE HAEMANGIOMA 2 0.0123
69 SLEEP DEFICIT 25 0.0118
70 AURA 22 0.0118
71 GENERALISED TONIC-CLONIC SEIZURE 191 0.0115
72 NEAR DROWNING 2 0.0114
73 ACQUIRED MACROGLOSSIA 1 0.0112
74 COVID-19 IMMUNISATION 9 0.0108
75 INTERNAL FIXATION OF FRACTURE 6 0.0105
76 PRODUCT AVAILABILITY ISSUE 237 0.0104
77 RIGHT ATRIAL ENLARGEMENT 2 0.0101
78 PRODUCT DISPENSING ISSUE 43 0.0100
79 AUTOMATISM 2 0.0093
80 LASER THERAPY 2 0.0089
81 SUSPICIOUSNESS 6 0.0085
82 HAEMANGIOMA CONGENITAL 4 0.0084
83 LIP INJURY 11 0.0084
84 CARDIAC SEPTAL DEFECT 6 0.0083
85 SCHIZOPHRENIFORM DISORDER 2 0.0082
86 HYPEREMESIS GRAVIDARUM 3 0.0078
87 EPILEPTIC AURA 2 0.0078
88 DEATH OF RELATIVE 3 0.0074
89 CRANIOTOMY 3 0.0073
90 INABILITY TO AFFORD MEDICATION 67 0.0067
91 MIGRAINE WITHOUT AURA 2 0.0067
92 HEPATORENAL FAILURE 4 0.0066
93 INTELLECTUAL DISABILITY 10 0.0066
94 ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT 2 0.0065
95 LIP HAEMORRHAGE 8 0.0063
96 THROMBECTOMY 2 0.0062
97 EPILEPSY 188 0.0061
98 HYPERMAGNESAEMIA 4 0.0061
99 MATERNAL EXPOSURE BEFORE PREGNANCY 40 0.0058
100 ATAXIA 69 0.0058
101 SELF-DESTRUCTIVE BEHAVIOUR 5 0.0057
102 INSURANCE ISSUE 86 0.0056
103 NONINFECTIVE ENCEPHALITIS 4 0.0056
104 MACROGLOSSIA 3 0.0055
105 FACIAL SPASM 6 0.0054
106 ENCEPHALITIS AUTOIMMUNE 7 0.0053
107 TRACHEITIS 4 0.0052
108 CEREBELLAR ATAXIA 5 0.0052
109 ENANTHEMA 3 0.0052
110 BREATH HOLDING 2 0.0052
111 ASTROCYTOMA 2 0.0051
112 TUMOUR EXCISION 4 0.0050
113 MATERNAL EXPOSURE DURING BREAST FEEDING 20 0.0049
114 ANHIDROSIS 2 0.0049
115 VACCINATION COMPLICATION 4 0.0049
116 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 13 0.0049
117 THERAPY INTERRUPTED 339 0.0047
118 MEDICAL INDUCTION OF COMA 2 0.0047
119 HYPERCHLORAEMIA 3 0.0047
120 MENINGOENCEPHALITIS HERPETIC 2 0.0045
121 ELECTROENCEPHALOGRAM ABNORMAL 14 0.0044
122 THERAPEUTIC PRODUCT INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0044
123 PHONOPHOBIA 2 0.0043
124 PARADOXICAL DRUG REACTION 16 0.0043
125 HYPERAMMONAEMIA 20 0.0040
126 ACETONAEMIA 1 0.0040
127 MYOCLONUS 47 0.0039
128 SEDATION COMPLICATION 10 0.0039
129 HYPERTROPHIC CARDIOMYOPATHY 6 0.0039
130 IMPULSIVE BEHAVIOUR 14 0.0037
131 IGA NEPHROPATHY 6 0.0036
132 GLIOBLASTOMA MULTIFORME 3 0.0036
133 PATENT DUCTUS ARTERIOSUS 14 0.0035
134 PRECOCIOUS PUBERTY 2 0.0035
135 CRANIOFACIAL FRACTURE 3 0.0035
136 TRACHEOSTOMY 5 0.0035
137 TONGUE PRURITUS 3 0.0035
138 SUTURE INSERTION 2 0.0034
139 TONGUE BITING 7 0.0034
140 NYSTAGMUS 18 0.0034
141 APRAXIA 5 0.0034
142 ACIDOSIS HYPERCHLORAEMIC 2 0.0034
143 DROP ATTACKS 2 0.0034
144 PRODUCT DISTRIBUTION ISSUE 31 0.0033
145 PRESCRIBED OVERDOSE 64 0.0033
146 SALIVARY HYPERSECRETION 33 0.0033
147 PROLONGED LABOUR 2 0.0033
148 HYPERSEXUALITY 6 0.0033
149 FEBRILE CONVULSION 4 0.0033
150 METAMORPHOPSIA 6 0.0033
151 GASTROSTOMY 5 0.0032
152 STEREOTYPY 3 0.0032
153 AGGRESSION 156 0.0031
154 SPINAL CORD DISORDER 5 0.0030
155 HIRSUTISM 4 0.0030
156 HYPERNATRAEMIA 15 0.0030
157 DROWNING 3 0.0030
158 SARS-COV-2 TEST NEGATIVE 2 0.0030
159 INGROWN HAIR 2 0.0029
160 POSTICTAL STATE 3 0.0029
161 ENDOTRACHEAL INTUBATION 8 0.0029
162 CLONIC CONVULSION 2 0.0027
163 BRAIN CONTUSION 2 0.0027
164 DRUG LEVEL BELOW THERAPEUTIC 15 0.0027
165 MECHANICAL VENTILATION 5 0.0026
166 PNEUMONIA PSEUDOMONAL 4 0.0026
167 CREATINE KINASE INCREASED 2 0.0026
168 FOLATE DEFICIENCY 3 0.0026
169 DAYDREAMING 4 0.0026
170 POLYCYSTIC OVARIES 4 0.0026
171 MEDICAL DEVICE IMPLANTATION 4 0.0025
172 JOINT NOISE 5 0.0025
173 SKULL FRACTURE 4 0.0025
174 SHOULDER FRACTURE 4 0.0024
175 PSYCHIATRIC SYMPTOM 18 0.0024
176 AFFECTIVE DISORDER 19 0.0024
177 DYSPNOEA AT REST 7 0.0024
178 CIRCADIAN RHYTHM SLEEP DISORDER 2 0.0024
179 CAMPYLOBACTER INFECTION 2 0.0024
180 EDUCATIONAL PROBLEM 4 0.0024
181 ANXIETY DISORDER 8 0.0024
182 GLIOBLASTOMA 4 0.0023
183 CRANIOCEREBRAL INJURY 7 0.0023
184 PRODUCT CONTAINER SEAL ISSUE 4 0.0023
185 ALOPECIA AREATA 4 0.0023
186 LARGE FOR DATES BABY 2 0.0023
187 SCHIZOAFFECTIVE DISORDER 4 0.0022
188 PARVOVIRUS B19 INFECTION 2 0.0022
189 MONOPARESIS 4 0.0022
190 BRADYPHRENIA 14 0.0021
191 MOOD SWINGS 68 0.0021
192 FANCONI SYNDROME 3 0.0021
193 GINGIVAL DISORDER 8 0.0021
194 CLEFT PALATE 4 0.0021
195 BRAIN NEOPLASM 19 0.0021
196 BLADDER CATHETERISATION 2 0.0021
197 REHABILITATION THERAPY 8 0.0021
198 ANKLE OPERATION 3 0.0020
199 DRUG RESISTANCE 52 0.0020
200 NORMAL NEWBORN 11 0.0020
201 BRAIN NEOPLASM MALIGNANT 9 0.0020
202 PSYCHOTIC BEHAVIOUR 2 0.0020
203 CONCUSSION 15 0.0019
204 WALKING DISABILITY 4 0.0019
205 CEREBRAL DISORDER 14 0.0019
206 BINGE EATING 2 0.0019
207 FACE INJURY 7 0.0018
208 RIGHT VENTRICULAR DYSFUNCTION 2 0.0018
209 QUADRIPARESIS 3 0.0018
210 IRRITABILITY 107 0.0018
211 STRESS AT WORK 2 0.0018
212 SEIZURE LIKE PHENOMENA 3 0.0018
213 READING DISORDER 4 0.0017
214 FEELING DRUNK 13 0.0017
215 CENTRAL NERVOUS SYSTEM INFECTION 2 0.0017
216 CHOREA 3 0.0017
217 MACROCYTOSIS 2 0.0017
218 ANGER 58 0.0017
219 WRONG PATIENT RECEIVED PRODUCT 5 0.0017
220 FACIAL PARESIS 6 0.0017
221 HEAD INJURY 53 0.0017
222 SUBCUTANEOUS ABSCESS 8 0.0017
223 DIPLOPIA 43 0.0017
224 VITAMIN D DEFICIENCY 16 0.0016
225 MATERNAL EXPOSURE DURING PREGNANCY 142 0.0016
226 BLOOD BICARBONATE DECREASED 3 0.0016
227 URINARY TRACT INFECTION BACTERIAL 4 0.0016
228 PREMATURE DELIVERY 25 0.0016
229 APGAR SCORE LOW 2 0.0016
230 ABDOMINAL WALL ABSCESS 1 0.0015
231 LIBIDO DISORDER 2 0.0015
232 TONIC CLONIC MOVEMENTS 2 0.0015
233 ENURESIS 6 0.0015
234 WRONG PRODUCT ADMINISTERED 10 0.0015
235 MIGRAINE WITH AURA 4 0.0015
236 B-LYMPHOCYTE COUNT DECREASED 2 0.0015
237 HEAD TITUBATION 2 0.0015
238 PARKINSONISM 14 0.0014
239 COGNITIVE DISORDER 67 0.0014
240 ECHOCARDIOGRAM ABNORMAL 2 0.0014
241 EYE CONTUSION 3 0.0014
242 ALVEOLITIS 2 0.0014
243 INTENSIVE CARE 2 0.0014
244 POST HERPETIC NEURALGIA 2 0.0014
245 OBSTRUCTIVE SLEEP APNOEA SYNDROME 2 0.0014
246 ABNORMAL BEHAVIOUR 54 0.0014
247 GENERALISED ANXIETY DISORDER 2 0.0014
248 MENTAL FATIGUE 2 0.0013
249 MOOD ALTERED 36 0.0013
250 GINGIVAL HYPERTROPHY 2 0.0013
251 PALLIATIVE CARE 2 0.0013
252 OESOPHAGEAL DISORDER 5 0.0013
253 OVERDOSE 277 0.0013
254 PULMONARY HAEMORRHAGE 10 0.0013
255 GESTATIONAL DIABETES 6 0.0013
256 EXPOSURE VIA BREAST MILK 5 0.0013
257 SOMNOLENCE 252 0.0013
258 STARING 3 0.0012
259 LISTLESS 4 0.0012
260 ACUTE PSYCHOSIS 3 0.0012
261 TACHYARRHYTHMIA 3 0.0012
262 ATTENTION DEFICIT HYPERACTIVITY DISORDER 5 0.0012
263 CATARACT OPERATION 7 0.0012
264 LAZINESS 2 0.0012
265 SUICIDAL IDEATION 107 0.0012
266 DRUG TITRATION ERROR 3 0.0012
267 PRIAPISM 4 0.0012
268 TONGUE COATED 2 0.0012
269 MEDICAL DEVICE REMOVAL 2 0.0012
270 SEDATION 30 0.0011
271 PREGNANCY ON ORAL CONTRACEPTIVE 3 0.0011
272 AFFECT LABILITY 11 0.0011
273 DEPRESSIVE SYMPTOM 4 0.0011
274 HALLUCINATION, AUDITORY 18 0.0011
275 THINKING ABNORMAL 21 0.0011
276 MENTAL DISORDER 49 0.0011
277 DRUG WITHDRAWAL CONVULSIONS 2 0.0011
278 OVERWEIGHT 6 0.0011
279 PRODUCT TAMPERING 2 0.0011
280 FACIAL BONES FRACTURE 4 0.0011
281 HIP SURGERY 6 0.0011
282 ENCEPHALOPATHY 27 0.0011
283 SCREAMING 7 0.0011
284 APATHY 16 0.0011
285 AUTISM SPECTRUM DISORDER 6 0.0011
286 HOMICIDE 2 0.0011
287 DISORGANISED SPEECH 2 0.0011
288 CATHETER PLACEMENT 2 0.0011
289 FEELING OF DESPAIR 5 0.0011
290 PERFORMANCE STATUS DECREASED 5 0.0011
291 NEPHROPATHY 10 0.0011
292 PSYCHOMOTOR RETARDATION 3 0.0011
293 ACTINOMYCOSIS 1 0.0010
294 CLAVICLE FRACTURE 4 0.0010
295 METABOLIC DISORDER 6 0.0010
296 HYPERSOMNIA 29 0.0010
297 PRODUCT PRESCRIBING ISSUE 22 0.0010
298 DYSARTHRIA 38 0.0010
299 BRAIN HERNIATION 3 0.0010
300 DEPRESSED MOOD 53 0.0010
301 MEMORY IMPAIRMENT 137 0.0010
302 PRODUCT USE ISSUE 185 0.0010
303 CHOLANGITIS SCLEROSING 2 0.0010
304 REBOUND EFFECT 11 0.0010
305 SPEECH DISORDER 51 0.0010
306 PERSONALITY CHANGE 9 0.0010
307 FAMILY STRESS 3 0.0010
308 BALANCE DISORDER 83 0.0010
309 PHYSICAL ASSAULT 2 0.0010
310 THERAPY NON-RESPONDER 43 0.0010
311 BLOOD PRESSURE DIASTOLIC DECREASED 7 0.0009
312 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 52 0.0009
313 HALLUCINATION, VISUAL 20 0.0009
314 FOETAL DISTRESS SYNDROME 2 0.0009
315 EXPOSURE TO TOXIC AGENT 3 0.0009
316 SHOULDER OPERATION 4 0.0009
317 CD4 LYMPHOCYTES DECREASED 2 0.0009
318 RESTLESSNESS 34 0.0009
319 JAW FRACTURE 2 0.0009
320 HYPONATRAEMIA 52 0.0009
321 WRIST FRACTURE 11 0.0009
322 PSYCHOTIC DISORDER 27 0.0009
323 DYSPHEMIA 4 0.0009
324 DRUG LEVEL INCREASED 15 0.0009
325 PSYCHOMOTOR HYPERACTIVITY 15 0.0009
326 BRAIN INJURY 9 0.0009
327 PREMATURE BABY 27 0.0009
328 ERECTILE DYSFUNCTION 23 0.0009
329 CALCINOSIS 2 0.0009
330 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 2 0.0009
331 DEPRESSED LEVEL OF CONSCIOUSNESS 35 0.0009
332 RENAL COLIC 2 0.0009
333 TRICUSPID VALVE INCOMPETENCE 7 0.0009
334 ALTERED STATE OF CONSCIOUSNESS 19 0.0009
335 ENCEPHALITIS 6 0.0009
336 HAEMANGIOMA 2 0.0009
337 NEUROLOGICAL DECOMPENSATION 2 0.0009
338 SOCIAL AVOIDANT BEHAVIOUR 5 0.0009
339 APHASIA 26 0.0009
340 CAESAREAN SECTION 10 0.0009
341 DISCOURAGEMENT 2 0.0009
342 DISTURBANCE IN SOCIAL BEHAVIOUR 2 0.0008
343 NEONATAL RESPIRATORY DISTRESS SYNDROME 3 0.0008
344 HYPOCALCAEMIA 16 0.0008
345 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 60 0.0008
346 APPENDICECTOMY 3 0.0008
347 COAGULOPATHY 14 0.0008
348 ANKLE FRACTURE 13 0.0008
349 OXYGEN CONSUMPTION INCREASED 2 0.0008
350 WEIGHT ABNORMAL 2 0.0008
351 WRONG DOSE 2 0.0008
352 HYPERACUSIS 3 0.0008
353 ANEURYSM 4 0.0008
354 SNORING 3 0.0008
355 INTENTIONAL SELF-INJURY 16 0.0008
356 FEEDING DISORDER 16 0.0008
357 INCREASED APPETITE 15 0.0008
358 COMMUNICATION DISORDER 3 0.0008
359 MUSCLE TWITCHING 18 0.0008
360 DYSTONIA 15 0.0008
361 VENTRICULAR EXTRASYSTOLES 8 0.0008
362 ADJUSTMENT DISORDER 1 0.0008
363 PRODUCT PACKAGING DIFFICULT TO OPEN 2 0.0008
364 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 2 0.0008
365 DISTURBANCE IN ATTENTION 41 0.0008
366 SUICIDE ATTEMPT 46 0.0008
367 ABNORMAL SLEEP-RELATED EVENT 1 0.0008
368 ADVERSE REACTION 10 0.0008
369 LEARNING DISABILITY 4 0.0008
370 ANIMAL BITE 2 0.0007
371 DRUG INTOLERANCE 72 0.0007
372 ARTERIOSCLEROSIS 7 0.0007
373 WEIGHT BEARING DIFFICULTY 2 0.0007
374 SPINAL FUSION SURGERY 3 0.0007
375 AMNESIA 48 0.0007
376 PRODUCT PACKAGING ISSUE 7 0.0007
377 SKIN LACERATION 8 0.0007
378 TIC 4 0.0007
379 SLEEP DISORDER 51 0.0007
380 HYPERTRANSAMINASAEMIA 5 0.0007
381 ATRIAL SEPTAL DEFECT 6 0.0007
382 DIABETIC COMA 2 0.0007
383 LIP OEDEMA 3 0.0007
384 THERMAL BURN 5 0.0007
385 BRAIN FOG 11 0.0007
386 OFF LABEL USE 613 0.0007
387 FALL 231 0.0007
388 HYSTERECTOMY 6 0.0007
389 CHAPPED LIPS 3 0.0007
390 STRESS CARDIOMYOPATHY 4 0.0007
391 PANIC ATTACK 25 0.0007
392 NEUROTOXICITY 12 0.0007
393 MAJOR DEPRESSION 5 0.0007
394 TOOTH DISCOLOURATION 2 0.0007
395 THORACIC VERTEBRAL FRACTURE 2 0.0007
396 CARDIAC PACEMAKER INSERTION 4 0.0007
397 URINE ANALYSIS ABNORMAL 2 0.0007
398 METABOLIC ENCEPHALOPATHY 2 0.0007
399 URINARY TRACT DISORDER 3 0.0007
400 SUSPECTED OFF LABEL USE 3 0.0007
401 JOINT DISLOCATION 7 0.0007
402 ECTOPIC PREGNANCY 2 0.0006
403 SKIN CANCER 14 0.0006
404 CONCOMITANT DISEASE AGGRAVATED 4 0.0006
405 ADVERSE DRUG REACTION 58 0.0006
406 TREATMENT NONCOMPLIANCE 35 0.0006
407 PARANOIA 11 0.0006
408 DRUG INTERACTION 100 0.0006
409 LOW BIRTH WEIGHT BABY 5 0.0006
410 LIMB INJURY 17 0.0006
411 HALLUCINATION 47 0.0006
412 STUPOR 2 0.0006
413 HEAD DISCOMFORT 11 0.0006
414 FRUSTRATION TOLERANCE DECREASED 5 0.0006
415 MENTAL IMPAIRMENT 15 0.0006
416 HYPOGAMMAGLOBULINAEMIA 4 0.0006
417 WALKING AID USER 4 0.0006
418 POOR QUALITY SLEEP 13 0.0006
419 APPETITE DISORDER 4 0.0006
420 RHABDOMYOLYSIS 25 0.0006
421 AGITATION 44 0.0006
422 POST-TRAUMATIC STRESS DISORDER 4 0.0006
423 DRUG LEVEL DECREASED 6 0.0006
424 ACCIDENT 7 0.0006
425 EMOTIONAL DISORDER 18 0.0006
426 CERVICAL VERTEBRAL FRACTURE 2 0.0006
427 HYPERBILIRUBINAEMIA 6 0.0006
428 EXPOSURE DURING PREGNANCY 36 0.0006
429 DEPRESSION SUICIDAL 2 0.0006
430 THERAPY PARTIAL RESPONDER 9 0.0006
431 DEPRESSION 130 0.0006
432 SPINAL OPERATION 7 0.0006
433 INCONTINENCE 6 0.0006
434 TREATMENT FAILURE 47 0.0006
435 HAND FRACTURE 4 0.0006
436 NEUTROPENIC SEPSIS 4 0.0006
437 LUPUS-LIKE SYNDROME 5 0.0006
438 HYPOKINESIA 8 0.0006
439 ROAD TRAFFIC ACCIDENT 23 0.0005
440 INTENTIONAL PRODUCT MISUSE 48 0.0005
441 ASPIRATION 6 0.0005
442 FOOD INTOLERANCE 2 0.0005
443 VIRAL MUTATION IDENTIFIED 2 0.0005
444 DEMENTIA 15 0.0005
445 NEPHROPATHY TOXIC 6 0.0005
446 TREMOR 88 0.0005
447 DISORIENTATION 21 0.0005
448 CATHETER SITE INFECTION 2 0.0005
449 CHEMOTHERAPY 2 0.0005
450 IMPAIRED DRIVING ABILITY 6 0.0005
451 HOSPITALISATION 81 0.0005
452 INTENTIONAL DOSE OMISSION 15 0.0005
453 SLEEP APNOEA SYNDROME 10 0.0005
454 ADRENAL DISORDER 1 0.0005
455 CONFUSIONAL STATE 84 0.0005
456 THERAPEUTIC PRODUCT INEFFECTIVE 2 0.0005
457 DYSKINESIA 21 0.0005
458 PANIC DISORDER 2 0.0005
459 DELUSION 8 0.0005
460 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
461 ORAL INFECTION 2 0.0005
462 PROCEDURAL HAEMORRHAGE 2 0.0005
463 KNEE OPERATION 5 0.0005
464 HOSPICE CARE 5 0.0005
465 CEREBRAL HAEMORRHAGE 18 0.0005
466 HYPOMAGNESAEMIA 7 0.0005
467 CEREBRAL ATROPHY 2 0.0005
468 TYPE 1 DIABETES MELLITUS 3 0.0005
469 DRUG INEFFECTIVE 656 0.0005
470 NERVOUSNESS 26 0.0005
471 MYASTHENIA GRAVIS 4 0.0005
472 TENSION 3 0.0005
473 MENISCUS INJURY 3 0.0005
474 INITIAL INSOMNIA 5 0.0005
475 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 5 0.0005
476 LETHARGY 28 0.0005
477 MANIA 8 0.0005
478 LEG AMPUTATION 2 0.0005
479 PNEUMONIA ASPIRATION 12 0.0005
480 UNINTENDED PREGNANCY 5 0.0005
481 DRUG-INDUCED LIVER INJURY 15 0.0005
482 SELF-INJURIOUS IDEATION 2 0.0005
483 BRAIN OEDEMA 6 0.0005
484 KNEE ARTHROPLASTY 10 0.0005
485 ABORTION SPONTANEOUS 19 0.0005
486 TONGUE DISCOMFORT 2 0.0005
487 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
488 EATING DISORDER 10 0.0005
489 CARDIAC FAILURE CHRONIC 2 0.0005
490 HEPATIC PAIN 2 0.0005
491 FOETAL EXPOSURE DURING PREGNANCY 38 0.0005
492 TENSION HEADACHE 2 0.0005
493 ANXIETY 132 0.0005
494 ATRIOVENTRICULAR BLOCK FIRST DEGREE 2 0.0005
495 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 93 0.0005
496 IMMOBILE 2 0.0005
497 INTERVERTEBRAL DISC PROTRUSION 10 0.0005
498 EOSINOPHILIA 8 0.0005
499 DISABILITY 9 0.0005
500 GINGIVAL SWELLING 2 0.0005
501 LIGAMENT RUPTURE 2 0.0005
502 LOSS OF CONSCIOUSNESS 58 0.0005
503 ACCIDENT AT WORK 1 0.0005
504 PHYSICAL DISABILITY 2 0.0005
505 UNDERDOSE 33 0.0005
506 PRODUCT SUBSTITUTION ISSUE 26 0.0005
507 DIZZINESS 225 0.0005
508 POSTOPERATIVE WOUND INFECTION 3 0.0004
509 GASTROENTERITIS VIRAL 8 0.0004
510 MITRAL VALVE INCOMPETENCE 5 0.0004
511 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
512 URINARY INCONTINENCE 13 0.0004
513 INTENTIONAL OVERDOSE 28 0.0004
514 NEPHROLITHIASIS 20 0.0004
515 SEASONAL ALLERGY 6 0.0004
516 PRODUCT DOSE OMISSION ISSUE 124 0.0004
517 BACTERAEMIA 5 0.0004
518 CONDITION AGGRAVATED 128 0.0004
519 MACULAR DEGENERATION 5 0.0004
520 LIMB OPERATION 2 0.0004
521 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 20 0.0004
522 HUMERUS FRACTURE 2 0.0004
523 STILLBIRTH 2 0.0004
524 SURGERY 24 0.0004
525 BODY TEMPERATURE DECREASED 4 0.0004
526 DELIRIUM 14 0.0004
527 UPPER LIMB FRACTURE 8 0.0004
528 HEPATIC ENZYME ABNORMAL 2 0.0004
529 SPINAL FRACTURE 8 0.0004
530 FEELING COLD 11 0.0004
531 VERTIGO 24 0.0004
532 HEPATIC CYTOLYSIS 5 0.0004
533 AMMONIA INCREASED 2 0.0004
534 PRODUCT COLOUR ISSUE 2 0.0004
535 ATRIOVENTRICULAR BLOCK 3 0.0004
536 APNOEA 3 0.0004
537 PERIORBITAL OEDEMA 2 0.0004
538 THERAPEUTIC RESPONSE UNEXPECTED 17 0.0004
539 PRODUCT PRESCRIBING ERROR 9 0.0004
540 OBESITY 6 0.0004
541 VIROLOGIC FAILURE 2 0.0004
542 BLOOD SODIUM DECREASED 7 0.0004
543 SYNCOPE 37 0.0004
544 DECUBITUS ULCER 3 0.0004
545 INSOMNIA 98 0.0004
546 HYDROCEPHALUS 2 0.0004
547 MIGRAINE 35 0.0004
548 LOWER LIMB FRACTURE 7 0.0004
549 PHOTOSENSITIVITY REACTION 6 0.0004
550 PROSTATIC DISORDER 2 0.0004
551 TRANSAMINASES INCREASED 8 0.0004
552 STREPTOCOCCAL INFECTION 2 0.0004
553 BLOOD PRESSURE SYSTOLIC INCREASED 7 0.0004
554 MALNUTRITION 4 0.0004
555 WEIGHT INCREASED 79 0.0004
556 PERONEAL NERVE PALSY 2 0.0004
557 FACIAL PARALYSIS 3 0.0004
558 PRODUCT CONTAINER ISSUE 3 0.0003
559 PARALYSIS 5 0.0003
560 CARDIAC OPERATION 3 0.0003
561 CORONARY ARTERY BYPASS 2 0.0003
562 ORTHOSTATIC HYPOTENSION 6 0.0003
563 RESPIRATORY SYNCYTIAL VIRUS INFECTION 3 0.0003
564 METABOLIC ACIDOSIS 11 0.0003
565 FLUID OVERLOAD 5 0.0003
566 PRODUCT USE IN UNAPPROVED INDICATION 85 0.0003
567 MOVEMENT DISORDER 11 0.0003
568 HIP FRACTURE 11 0.0003
569 URINE ODOUR ABNORMAL 2 0.0003
570 GAIT DISTURBANCE 65 0.0003
571 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
572 MUSCLE RIGIDITY 4 0.0003
573 INTENTIONAL PRODUCT USE ISSUE 29 0.0003
574 OPTIC NEURITIS 3 0.0003
575 SKIN LESION 9 0.0003
576 RESPIRATORY DEPRESSION 4 0.0003
577 NERVE COMPRESSION 3 0.0003
578 FATIGUE 253 0.0003
579 PIGMENTATION DISORDER 2 0.0003
580 EPSTEIN-BARR VIRUS INFECTION 2 0.0003
581 LEUKAEMIA 3 0.0003
582 PRODUCT DOSE OMISSION IN ERROR 9 0.0003
583 ANGIOEDEMA 14 0.0003
584 PHOTOPSIA 2 0.0003
585 ATELECTASIS 3 0.0003
586 THERAPY CHANGE 3 0.0003
587 DYSGRAPHIA 2 0.0003
588 CEREBROVASCULAR ACCIDENT 51 0.0003
589 MENINGITIS 2 0.0003
590 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
591 CORONARY ARTERY DISEASE 9 0.0003
592 HEMIPARESIS 5 0.0003
593 THROMBOCYTOPENIA 33 0.0003
594 COMA 14 0.0003
595 AKATHISIA 4 0.0003
596 MULTIPLE SCLEROSIS 14 0.0003
597 INFARCTION 2 0.0003
598 RIB FRACTURE 6 0.0003
599 PRODUCT DOSE OMISSION 19 0.0003
600 DROOLING 2 0.0003
601 NEURALGIA 7 0.0003
602 APHONIA 4 0.0003
603 LIVER INJURY 7 0.0003
604 SCRATCH 3 0.0003
605 DECREASED APPETITE 66 0.0003
606 FEELING ABNORMAL 68 0.0003
607 IMPAIRED WORK ABILITY 6 0.0003
608 PRODUCT SUPPLY ISSUE 2 0.0003
609 LEUKOPENIA 14 0.0003
610 SUBDURAL HAEMATOMA 4 0.0003
611 TOXICITY TO VARIOUS AGENTS 47 0.0003
612 PARAESTHESIA ORAL 4 0.0003
613 ABDOMINAL PAIN LOWER 7 0.0003
614 VISUAL FIELD DEFECT 2 0.0003
615 BIPOLAR DISORDER 3 0.0003
616 PULMONARY THROMBOSIS 3 0.0003
617 WOUND INFECTION 3 0.0003
618 TOOTH FRACTURE 3 0.0003
619 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 49 0.0003
620 ADVERSE EVENT 25 0.0003
621 INJURY 19 0.0003
622 HEPATIC STEATOSIS 5 0.0003
623 BACTERIAL INFECTION 5 0.0003
624 FOOT FRACTURE 5 0.0003
625 TROPONIN INCREASED 2 0.0003
626 HYPERTHERMIA 2 0.0003
627 HEADACHE 164 0.0003
628 NEOPLASM 3 0.0003
629 CHOLESTASIS 5 0.0003
630 LIMB DISCOMFORT 8 0.0003
631 RASH PRURITIC 14 0.0003
632 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
633 HYPOALBUMINAEMIA 2 0.0003
634 HAEMORRHAGIC STROKE 2 0.0003
635 MENTAL STATUS CHANGES 7 0.0003
636 CATARACT 15 0.0003
637 OBSESSIVE-COMPULSIVE DISORDER 2 0.0002
638 HYPERSENSITIVITY 46 0.0002
639 VISION BLURRED 34 0.0002
640 PRODUCT ADMINISTRATION ERROR 5 0.0002
641 MULTIPLE ORGAN DYSFUNCTION SYNDROME 7 0.0002
642 SCHIZOPHRENIA 3 0.0002
643 TASTE DISORDER 5 0.0002
644 POST PROCEDURAL INFECTION 2 0.0002
645 CARDIAC ARREST 20 0.0002
646 SPINAL COMPRESSION FRACTURE 2 0.0002
647 HEMIPLEGIA 2 0.0002
648 NEOPLASM MALIGNANT 16 0.0002
649 GAIT INABILITY 8 0.0002
650 LIVE BIRTH 2 0.0002
651 HYPOPHAGIA 6 0.0002
652 ABSCESS LIMB 1 0.0002
653 GASTROINTESTINAL DISORDER 21 0.0002
654 PSEUDOMONAS INFECTION 2 0.0002
655 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 6 0.0002
656 UNRESPONSIVE TO STIMULI 6 0.0002
657 HAEMATOMA 6 0.0002
658 MYOPATHY 2 0.0002
659 RASH ERYTHEMATOUS 11 0.0002
660 BEDRIDDEN 3 0.0002
661 ORAL CANDIDIASIS 3 0.0002
662 PRODUCT COMMUNICATION ISSUE 2 0.0002
663 TACHYCARDIA 20 0.0002
664 STEVENS-JOHNSON SYNDROME 5 0.0002
665 FEAR 6 0.0002
666 URINARY TRACT INFECTION 38 0.0002
667 LOSS OF LIBIDO 2 0.0002
668 HEAVY MENSTRUAL BLEEDING 2 0.0002
669 OROPHARYNGEAL DISCOMFORT 2 0.0002
670 DYSPHAGIA 21 0.0002
671 GINGIVAL BLEEDING 3 0.0002
672 HYPERGLYCAEMIA 8 0.0002
673 PATHOGEN RESISTANCE 2 0.0002
674 VOMITING 103 0.0002
675 ACCIDENTAL OVERDOSE 8 0.0002
676 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
677 RESPIRATORY DISTRESS 6 0.0002
678 INCREASED TENDENCY TO BRUISE 2 0.0002
679 IRON DEFICIENCY ANAEMIA 2 0.0002
680 COMPLETED SUICIDE 18 0.0002
681 CARDIO-RESPIRATORY ARREST 9 0.0002
682 COORDINATION ABNORMAL 3 0.0002
683 WEIGHT DECREASED 60 0.0002
684 WOUND 6 0.0002
685 CARPAL TUNNEL SYNDROME 3 0.0002
686 MIDDLE INSOMNIA 4 0.0002
687 FLANK PAIN 2 0.0002
688 ABORTION INDUCED 2 0.0002
689 FRACTURE 4 0.0002
690 SINUS TACHYCARDIA 3 0.0002
691 SPINAL DISORDER 2 0.0002
692 EYE INFLAMMATION 2 0.0002
693 MOBILITY DECREASED 15 0.0002
694 BRADYCARDIA 11 0.0002
695 HYPERCHOLESTEROLAEMIA 2 0.0002
696 INCORRECT DOSE ADMINISTERED 47 0.0002
697 EAR PAIN 4 0.0002
698 COVID-19 36 0.0002
699 CHOKING 4 0.0002
700 ILLNESS 21 0.0002
701 DECREASED IMMUNE RESPONSIVENESS 2 0.0002
702 HEPATOMEGALY 2 0.0002
703 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
704 COLON CANCER 3 0.0002
705 THERAPEUTIC PRODUCT EFFECT DECREASED 9 0.0002
706 HYPOAESTHESIA ORAL 3 0.0002
707 HEPATIC FAILURE 6 0.0002
708 HYPOXIA 7 0.0002
709 TOXIC EPIDERMAL NECROLYSIS 3 0.0002
710 CONTUSION 19 0.0002
711 SUBARACHNOID HAEMORRHAGE 2 0.0002
712 MOTOR DYSFUNCTION 2 0.0002
713 SLUGGISHNESS 2 0.0002
714 HIP ARTHROPLASTY 3 0.0002
715 TOOTH LOSS 4 0.0002
716 MENINGIOMA 3 0.0002
717 RESPIRATORY FAILURE 14 0.0002
718 PNEUMONIA 62 0.0002
719 TRANSFUSION 2 0.0002
720 PRODUCT USE COMPLAINT 3 0.0002
721 GENERAL PHYSICAL HEALTH DETERIORATION 22 0.0002
722 DISEASE RECURRENCE 9 0.0002
723 JOINT INJURY 4 0.0002
724 VISUAL IMPAIRMENT 23 0.0002
725 DECREASED ACTIVITY 2 0.0002
726 BACK INJURY 2 0.0002
727 PRODUCT DISPENSING ERROR 4 0.0002
728 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
729 MULTIPLE FRACTURES 3 0.0002
730 RESPIRATORY ARREST 5 0.0002
731 RASH 79 0.0002
732 ABNORMAL DREAMS 5 0.0002
733 MEDICATION ERROR 10 0.0002
734 RASH MACULO-PAPULAR 4 0.0002
735 PANCYTOPENIA 10 0.0002
736 TRANSIENT ISCHAEMIC ATTACK 6 0.0002
737 TARDIVE DYSKINESIA 5 0.0002
738 MUSCULAR WEAKNESS 20 0.0002
739 INTERNATIONAL NORMALISED RATIO INCREASED 5 0.0002
740 MYOCARDITIS 2 0.0002
741 HERPES ZOSTER 10 0.0002
742 UPPER RESPIRATORY TRACT INFECTION 8 0.0002
743 PERICARDIAL EFFUSION 4 0.0002
744 DRY MOUTH 14 0.0002
745 MADAROSIS 2 0.0002
746 ELECTROLYTE IMBALANCE 2 0.0002
747 BLINDNESS 7 0.0002
748 HEART RATE DECREASED 6 0.0002
749 SEXUAL DYSFUNCTION 2 0.0002
750 COVID-19 PNEUMONIA 2 0.0002
751 DRUG ERUPTION 3 0.0002
752 SYSTEMIC LUPUS ERYTHEMATOSUS 6 0.0002
753 NEUROLEPTIC MALIGNANT SYNDROME 2 0.0002
754 THIRST 3 0.0002
755 BLOOD PRESSURE FLUCTUATION 4 0.0002
756 LEUKOCYTOSIS 3 0.0002
757 NOCTURIA 2 0.0002
758 CYTOPENIA 2 0.0002
759 HAEMATOCHEZIA 9 0.0002
760 ALOPECIA 32 0.0002
761 AGRANULOCYTOSIS 3 0.0002
762 CYST 2 0.0002
763 TOOTH EXTRACTION 2 0.0002
764 NERVOUS SYSTEM DISORDER 5 0.0002
765 OXYGEN SATURATION DECREASED 9 0.0002
766 DERMATITIS ALLERGIC 2 0.0002
767 CYSTITIS 5 0.0002
768 POST PROCEDURAL COMPLICATION 3 0.0002
769 ACUTE RESPIRATORY FAILURE 3 0.0002
770 MYDRIASIS 2 0.0002
771 THERAPY CESSATION 8 0.0002
772 HYPOTENSION 31 0.0002
773 ASTHENIA 58 0.0002
774 HAEMORRHOIDS 3 0.0002
775 RESPIRATORY TRACT INFECTION 4 0.0002
776 NODULE 2 0.0002
777 GASTRITIS 4 0.0002
778 IMMUNE SYSTEM DISORDER 2 0.0002
779 SARS-COV-2 TEST POSITIVE 2 0.0002
780 BLOOD PRESSURE ABNORMAL 3 0.0002
781 QUALITY OF LIFE DECREASED 2 0.0001
782 PRODUCT PHYSICAL ISSUE 3 0.0001
783 THERAPEUTIC RESPONSE DECREASED 9 0.0001
784 ARRHYTHMIA 7 0.0001
785 OEDEMA 8 0.0001
786 ACUTE HEPATIC FAILURE 2 0.0001
787 OSTEOPOROSIS 6 0.0001
788 PYREXIA 50 0.0001
789 NIGHTMARE 5 0.0001
790 HUNGER 2 0.0001
791 SEPSIS 16 0.0001
792 MASS 2 0.0001
793 SKIN REACTION 2 0.0001
794 NAUSEA 112 0.0001
795 HYPOAESTHESIA 21 0.0001
796 LIVER FUNCTION TEST INCREASED 3 0.0001
797 HYPERTHYROIDISM 2 0.0001
798 DYSSTASIA 4 0.0001
799 GASTROOESOPHAGEAL REFLUX DISEASE 11 0.0001
800 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
801 TOOTH DISORDER 3 0.0001
802 IMMUNODEFICIENCY 2 0.0001
803 ORAL PAIN 3 0.0001
804 BLOOD POTASSIUM DECREASED 4 0.0001
805 HYPERTENSION 28 0.0001
806 HEPATIC ENZYME INCREASED 9 0.0001
807 OSTEOPENIA 2 0.0001
808 TINNITUS 6 0.0001
809 ALANINE AMINOTRANSFERASE INCREASED 8 0.0001
810 HYPOKALAEMIA 6 0.0001
811 LYMPHOMA 2 0.0001
812 FEMUR FRACTURE 4 0.0001
813 CYANOSIS 2 0.0001
814 MYOCARDIAL INFARCTION 22 0.0001
815 RESPIRATORY TRACT CONGESTION 2 0.0001
816 HYPOTHYROIDISM 4 0.0001
817 NEUTROPENIA 17 0.0001
818 THROMBOSIS 10 0.0001
819 NIGHT SWEATS 4 0.0001
820 PARAESTHESIA 19 0.0001
821 VIRAL INFECTION 4 0.0001
822 LIP SWELLING 4 0.0001
823 POLLAKIURIA 5 0.0001
824 CONSTIPATION 26 0.0001
825 MUSCULOSKELETAL DISCOMFORT 2 0.0001
826 HYPOACUSIS 5 0.0001
827 MUSCULOSKELETAL STIFFNESS 10 0.0001
828 METASTASES TO LIVER 2 0.0001
829 LYMPHOCYTE COUNT DECREASED 2 0.0001
830 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
831 LYMPHADENOPATHY 4 0.0001
832 EAR INFECTION 3 0.0001
833 GALLBLADDER DISORDER 2 0.0001
834 MALAISE 49 0.0001
835 THROAT IRRITATION 5 0.0001
836 NO ADVERSE EVENT 20 0.0001
837 CRYING 4 0.0001
838 RESTLESS LEGS SYNDROME 2 0.0001
839 DISEASE PROGRESSION 13 0.0001
840 BONE DISORDER 2 0.0001
841 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 2 0.0001
842 ARTHROPATHY 6 0.0001
843 URTICARIA 18 0.0001
844 HEPATIC CIRRHOSIS 2 0.0001
845 PHOTOPHOBIA 2 0.0001
846 UNEVALUABLE EVENT 8 0.0001
847 PROTEINURIA 2 0.0001
848 GLAUCOMA 2 0.0001
849 DEATH 89 0.0001
850 CHEST PAIN 19 0.0001
851 KIDNEY INFECTION 2 0.0001
852 PRURITUS 39 0.0001
853 SINUS DISORDER 2 0.0001
854 RESPIRATORY DISORDER 3 0.0001
855 DRY EYE 5 0.0001
856 CARDIAC FAILURE 8 0.0001
857 NEUTROPHIL COUNT DECREASED 4 0.0001
858 ACUTE KIDNEY INJURY 15 0.0001
859 INJECTION SITE RASH 3 0.0001
860 CHEST DISCOMFORT 10 0.0001
861 NASOPHARYNGITIS 18 0.0001
862 DEHYDRATION 13 0.0001
863 INFLAMMATION 5 0.0001
864 COUGH 27 0.0001
865 SWOLLEN TONGUE 3 0.0001
866 HAEMORRHAGE 10 0.0001
867 DERMATITIS 2 0.0001
868 ABDOMINAL DISCOMFORT 16 0.0001
869 MOUTH ULCERATION 2 0.0001
870 BRONCHITIS 7 0.0001
871 ANAEMIA 18 0.0001
872 ASPARTATE AMINOTRANSFERASE INCREASED 5 0.0001
873 DIABETES MELLITUS 7 0.0001
874 EYE DISORDER 3 0.0001
875 URINARY RETENTION 3 0.0001
876 INFECTION 13 0.0001
877 SNEEZING 2 0.0001
878 PANCREATITIS ACUTE 2 0.0001
879 CHROMATURIA 2 0.0001
880 MULTIPLE SCLEROSIS RELAPSE 6 0.0001
881 SKIN DISCOLOURATION 4 0.0001
882 SHOCK 2 0.0001
883 DYSPNOEA 49 0.0001
884 BREAST CANCER 8 0.0001
885 BLOOD CHOLESTEROL INCREASED 4 0.0001
886 PERIPHERAL SWELLING 13 0.0001
887 C-REACTIVE PROTEIN INCREASED 3 0.0001
888 ATRIAL FIBRILLATION 8 0.0001
889 CEREBRAL INFARCTION 2 0.0001
890 DYSPEPSIA 8 0.0001
891 INFLUENZA 9 0.0001
892 HAEMATEMESIS 2 0.0001
893 FLUID RETENTION 4 0.0001
894 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
895 RASH GENERALISED 2 0.0001
896 ABDOMINAL DISTENSION 8 0.0001
897 DEAFNESS 2 0.0001
898 JOINT STIFFNESS 2 0.0001
899 PANCREATITIS 4 0.0001
900 FEBRILE NEUTROPENIA 5 0.0001
901 PLATELET COUNT DECREASED 8 0.0001
902 MENSTRUATION IRREGULAR 2 0.0001
903 WHITE BLOOD CELL COUNT DECREASED 8 0.0001
904 DIVERTICULITIS 2 0.0001
905 BLOOD PRESSURE INCREASED 11 0.0001
906 NECK PAIN 4 0.0001
907 BURNING SENSATION 5 0.0001
908 DIARRHOEA 46 0.0001
909 HYPERHIDROSIS 9 0.0001
910 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
911 BACK PAIN 16 0.0001
912 LIVER FUNCTION TEST ABNORMAL 2 0.0001
913 DYSPHONIA 4 0.0001
914 PALPITATIONS 8 0.0001
915 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
916 ASCITES 2 0.0001
917 COLITIS ULCERATIVE 3 0.0001
918 PULMONARY OEDEMA 3 0.0001
919 LACRIMATION INCREASED 2 0.0001
920 DISCOMFORT 4 0.0001
921 SKIN IRRITATION 3 0.0001
922 BLOOD GLUCOSE DECREASED 3 0.0001
923 PAIN 38 0.0001
924 DEEP VEIN THROMBOSIS 4 0.0001
925 SWELLING FACE 4 0.0001
926 CHOLELITHIASIS 2 0.0001
927 STAPHYLOCOCCAL INFECTION 2 0.0001
928 RENAL FAILURE 8 0.0001
929 BLOOD PRESSURE DECREASED 4 0.0001
930 ABDOMINAL PAIN 14 0.0001
931 SKIN DISORDER 2 0.0001
932 RENAL IMPAIRMENT 5 0.0001
933 PAIN IN EXTREMITY 17 0.0001
934 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
935 ECZEMA 3 0.0001
936 DRUG EFFECT INCOMPLETE 2 0.0001
937 DYSGEUSIA 4 0.0001
938 ABDOMINAL PAIN UPPER 11 0.0001
939 SWELLING 5 0.0001
940 EYE PAIN 3 0.0001
941 ASTHMA 6 0.0001
942 INTESTINAL OBSTRUCTION 2 0.0001
943 COLITIS 2 0.0001
944 DRY SKIN 7 0.0001
945 BONE PAIN 3 0.0001
946 PROSTATE CANCER 4 0.0000
947 EMOTIONAL DISTRESS 6 0.0000
948 EXTRA DOSE ADMINISTERED 2 0.0000
949 PLEURAL EFFUSION 3 0.0000
950 MUSCLE SPASMS 9 0.0000
951 FEELING HOT 3 0.0000
952 SINUSITIS 5 0.0000
953 LUNG NEOPLASM MALIGNANT 2 0.0000
954 MYALGIA 8 0.0000
955 DEVICE DISLOCATION 2 0.0000
956 SEPTIC SHOCK 2 0.0000
957 BLOOD CREATININE INCREASED 3 0.0000
958 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
959 RENAL DISORDER 2 0.0000
960 CARDIAC DISORDER 4 0.0000
961 DEVICE MALFUNCTION 3 0.0000
962 OCULAR HYPERAEMIA 2 0.0000
963 PRODUCTIVE COUGH 2 0.0000
964 HYPOGLYCAEMIA 2 0.0000
965 LUNG DISORDER 2 0.0000
966 HEART RATE INCREASED 4 0.0000
967 EPISTAXIS 3 0.0000
968 CHRONIC KIDNEY DISEASE 3 0.0000
969 ARTHRITIS 3 0.0000
970 PRODUCT QUALITY ISSUE 5 0.0000
971 INFLUENZA LIKE ILLNESS 3 0.0000
972 ARTHRALGIA 15 0.0000
973 JOINT SWELLING 4 0.0000
974 OEDEMA PERIPHERAL 4 0.0000
975 OROPHARYNGEAL PAIN 3 0.0000
976 PULMONARY EMBOLISM 3 0.0000
977 NEUROPATHY PERIPHERAL 3 0.0000
978 RHINORRHOEA 2 0.0000
979 HAEMOGLOBIN DECREASED 3 0.0000
980 ERYTHEMA 6 0.0000
981 HOT FLUSH 2 0.0000
982 ACNE 2 0.0000
983 INJECTION SITE SWELLING 2 0.0000
984 CHILLS 3 0.0000
985 DRUG ABUSE 2 0.0000
986 SKIN EXFOLIATION 2 0.0000
987 PSORIASIS 3 0.0000
988 BLOOD GLUCOSE INCREASED 4 0.0000
989 FLUSHING 2 0.0000
990 DRUG DEPENDENCE 2 0.0000
991 DRUG DOSE OMISSION 2 0.0000
992 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000